XAIR - Beyond Air Inc logo

XAIR

Beyond Air Inc

Beyond Air develops the Lungfit platform, a nitric oxide generator for treating respiratory and neurological conditions. Its products include Lungfit PH for pulmonary hypertension and Lungfit PRO for viral lung infections, with ongoing clinical trials.

βš•οΈ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 5 years ago β†’$2today

Score Overview

1 Year
Score
Net Growth28.69%
Net TrendGrew
Net Income Consistencyβ€”
Rev Growth107.26%
Rev TrendGrew
Revenue Consistencyβ€”
5 Years
Score4.4
Net Growth-45.35%
Net Trend40%
Net Income Consistencyβ€”
Rev Growth8x
Rev Trend60%
Revenue Consistencyβ€”
All Time
Scoreβ€”
Net Growth-84.27%
Net Trend38%
Net Income Consistency
Rev Growthβ€”
Rev Trend50%
Revenue Consistency

See the full market ranking β†’

Beyond Air Inc fundamental performance

Between 2021 and 2026, revenue grew from $ 873K to $ 7M and net income went from -$ 22M to -$ 33M. Revenue increased in 3 of those 5 years; net income in 2.

Beyond Air Inc currently holds a 5-year HDB Score of 4.4 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 6.05β€”
1 Year2025-08-12
$ 63.20-90.43%
5 Years2021-08-12
$ 3.2K-99.81%
All Time2017-09-22
$ 5.755.22%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 7M-$ 33M$ 11M
2025$ 3M-$ 46M$ 6M
2024$ 1M-$ 60M$ 34M
2023$ 59K-$ 55M$ 45M
2022$ 145.19K-$ 43M$ 80M
2021$ 873K-$ 22M$ 34M
2020$ 1M-$ 19M$ 19M
2019$ 7M-$ 6M$ 7M
2018$ 0.00-$ 18M$ 9M

Explore beyond XAIR

You're looking at Beyond Air Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies